VK

Venkatesh Kancha

Active Director Director DIN 07657140
DIN 07657140 First appointment Nov 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2016
Shareholding value •••• Premium profile

About Venkatesh Kancha

Data last updated:

Venkatesh Kancha is a Director at Medmore Pharma Private Limited (since 2016). The company operates in Pharma. Medmore Pharma Private Limited reported revenue of ₹93.1 Lakh (FY 2025).

DIN 07657140
Primary Designation Director
Industry Pharma
First Appointment 22 Nov 2016
Oldest Company Age 9 yrs
Largest company Medmore Pharma Private Limited · ₹93.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medmore Pharma Private Limited U24303TG2016PTC113051
Director22 Nov 20162016₹93.1 Lakh (FY 2025)Active

Board colleagues of Venkatesh Kancha

NameDINCompanyDesignation
Sandhya Kancha08579859Medmore Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medmore Pharma Private Limited
Premium access

Shareholding and investment profile for Venkatesh Kancha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkatesh Kancha

Venkatesh Kancha currently holds 1 directorship: Medmore Pharma Private Limited (Director, since 22 Nov 2016, revenue ₹93.1 Lakh (FY 2025)).

Venkatesh Kancha was first appointed on 22 Nov 2016 as Director at Medmore Pharma Private Limited.

The current boards of Venkatesh Kancha's companies include Sandhya Kancha (Medmore Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available